$25.36
At close: May 13 EDT
Tools
Free Benzinga Pro Trial
Calendars
Trade Ideas
Short Interest
Comments
Loading...
Columbia Research Enhanced Value ETF Stock Price, Quotes and Forecasts
REVSARCA
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Sector
Financial Services
Region
US
AUM
39.72M
Fund Score
Columbia Research Enhanced Value ETF Price, Quotes and Forecasts | ARCA:REVS | Benzinga
Explore Columbia Research Enhanced Value ETF stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for REVS.
| Open | - |
| High | - |
| 52 Wk High | $27.03 |
| AUM | 39.72M |
| Dividend | $0.47 |
| Ex-Div Date | Dec 18, 2024 |
| Volume | - |
| Market Cap | $147.13B |
| Mgmt Fee | 0.19% |
| P/E Ratio | 16.56 |
| Prev. Close | $25.36 |
| Low | - |
| 52 Wk Low | $21.79 |
| Shares Out | 1.80M |
| Yield | 1.84% |
| Div. Freq | Annual |
| Avg. Volume Daily | 21.68K |
| Beta | 0.85 |
| Avg. Expense Ratio | 0.19% |
| P/B Ratio | 2.31 |
Recent News
FAQ
Q
How do I buy Columbia Research Enhanced Value ETF (REVS) stock?
A
You can purchase shares of Columbia Research Enhanced Value ETF (ARCA:REVS) through any online brokerage.
Q
Who are Columbia Research Enhanced Value ETF (REVS) competitors?
A
There are no as such competitors for Columbia Research Enhanced Value ETF.
Q
What is the forecast, or price target, for Columbia Research Enhanced Value ETF (REVS) stock?
A
There is no analysis for Columbia Research Enhanced Value ETF to provide a consensus price target.
Q
What is the current price for Columbia Research Enhanced Value ETF (REVS)?
A
The stock price for Columbia Research Enhanced Value ETF (ARCA: REVS) is $25.3585 last updated May 13, 2025 at 8:00 PM EDT.
Q
Does Columbia Research Enhanced Value ETF (REVS) pay a dividend?
A
A quarterly cash dividend of 0.47 per share of Class A Common Stock. The quarterly cash dividend was payable on December 26, 2024 to stockholders of record on December 18, 2024.
Q
When is Columbia Research Enhanced Value ETF (ARCA:REVS) reporting earnings?
A
Columbia Research Enhanced Value ETF does not have any upcoming earnings scheduled.
Q
Is Columbia Research Enhanced Value ETF (REVS) going to split?
A
There is no upcoming split for Columbia Research Enhanced Value ETF.
| Open | - |
| High | - |
| 52 Wk High | $27.03 |
| AUM | 39.72M |
| Dividend | $0.47 |
| Ex-Div Date | Dec 18, 2024 |
| Volume | - |
| Market Cap | $147.13B |
| Mgmt Fee | 0.19% |
| P/E Ratio | 16.56 |
| Prev. Close | $25.36 |
| Low | - |
| 52 Wk Low | $21.79 |
| Shares Out | 1.80M |
| Yield | 1.84% |
| Div. Freq | Annual |
| Avg. Volume Daily | 21.68K |
| Beta | 0.85 |
| Avg. Expense Ratio | 0.19% |
| P/B Ratio | 2.31 |
About Columbia ETF Trust I
Sector
N/A
Industry
N/A
ETF Details
| Sector | Financial Services |
| Category | Mid Performer-High Growth |
| Investment Style | Large Cap Value |
| Fund Inception | Sep 25, 2019 |
| Managers | Henry Hom Christopher Lo Jason Wang |
| Definition | Stocks with average financial performance and superior growth potential lead this equity fund portfolio |
Investment Policy
The Fund is an exchange-traded fund (ETF) that seeks to replicate the performance of the Index. The Fund invests at least 80% of its assets in the securities of the Index. The Index reflects a rules-based strategic beta approach to investing in the companies that comprise the Russell 1000 Value Index, designed to achieve stronger total return when compared to the Russell 1000 Value Index, which is a broad measure of the performance of U.S. large- and mid-cap value companies. The Index, like the Russell 1000 Value Index, and therefore the Fund, typically holds only common stocks.
Top ETF Holdings
| Symbol | Name | Share % |
|---|---|---|
| JNJ | Johnson & Johnson | 5.35% |
| JPM | Jpmorgan Chase & Co | 5.15% |
| XOM | Exxonmobil Corp. | 2.75% |
| CSCO | Cisco Systems, Inc. | 3.61% |
| PM | Philip Morris Internat... | 3.62% |
| WFC | Wells Fargo & Co. | 2.13% |
| CAT | Caterpillar Inc | 1.58% |
| CVX | Chevron Corp. | 1.59% |
| IE | Medtronic Plc | 2.48% |
| BMY | Bristol-Myers Squibb C... | 2.34% |
| RTX | Raytheon Co. | 1.97% |
| MX | United Technologies Co... | 2.01% |
Market Resources
Trading Tools & Education
- Benzinga Pro Trading Platform
- Options Trading Strategies and News
- Stock Market Trading Ideas and Analysis
- Technical Analysis Charts and Indicators
- Fundamental Analysis and Valuation
- Day Trading Guides and Strategies
- Live Investors Events
- Pre market Stock Analysis and News
- Cryptocurrency Market Analysis and News
Ring the Bell
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
© 2025 Benzinga | All Rights Reserved